Clik here to view.
ソウル半導体、欧州で「ヒューマンセントリック照明と健康」をテーマとするシンポジウムを開催
韓国安山市 （ビジネスワイヤ） — 世界的なLED （発光ダイオード）専業メーカーのSeoul Semiconductor Co., Ltd. (本社：韓国安山市、代表理事：李貞勲、以下「ソウル半導体」)は、光が健康と生体リズムに与える影響を、科学的、客観的に究明したシンポジウムを、世界最大級の照明展示会Light &...
View ArticleClik here to view.
Dr. Reddy’s Laboratories and its U.S. subsidiary Promius Pharma announce the...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and its subsidiary, Promius Pharma, LLC today announced the filing of New Drug Application...
View ArticleClik here to view.
AVITA Medical Announces Schedule for Six RECELL® Device Presentations at...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) announced today new data to be presented describing clinical and cost-savings advantages of RECELL® Device in the...
View ArticleClik here to view.
レスメドがボビー・ゴシャールを初の最高技術責任者として採用
サンディエゴ （ビジネスワイヤ） — レスメド（NYSE: RMD、ASX: RMD）は本日、当社初の最高技術責任者（CTO）としてボビー・ゴシャールを本日付で採用したと発表しました。 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。： https://www.businesswire.com/news/home/20180403006456/ja/...
View ArticleClik here to view.
瑞思迈聘用Bobby Ghoshal担任首任首席技术官
圣迭戈 (美国商业资讯)–瑞思迈(ResMed, NYSE: RMD, ASX:RMD)今天宣布，该公司对第一任首席技术官(CTO) Bobby Ghoshal的任命即日生效。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20180403006725/zh-CN/ Bobby Ghoshal, ResMed Chief...
View ArticleClik here to view.
Clik here to view.
Pacific Prime Receives Bupa Global’s Best Performance – Intermediary Award
HONG KONG Pacific Prime is pleased to announce that they have been honored with the ‘Best Performance Award – Intermediary’ from Bupa Global at their annual APAC conference. Held annually, this...
View ArticleClik here to view.
CANbridge Receives Approval to Commence CAN008 Phase II/III Trial in...
BEIJING, China CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that the China Food and Drug Administration...
View ArticleClik here to view.
Clik here to view.
ハートサイエンシズが臨床試験結果のJournal of the American College of Cardiology（JACC）への掲載を発表
米テキサス州サウスレイク （ビジネスワイヤ） —...
View ArticleClik here to view.
RECELL® Study in Facial Burns Shows Excellent Cosmetic Outcomes
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) announced today results from a clinical study highlighting the potential benefits of the RECELL® Autologous Cell...
View ArticleClik here to view.
Patient Safety Movement Foundation Supports the Tokyo Declaration on Patient...
IRVINE, Calif. The Patient Safety Movement Foundation (PSMF) announced its support for the Tokyo Declaration on Patient Safety, which was put forward by Japan, Germany, and the United Kingdom at the...
View ArticleClik here to view.
RECELL® Pivotal Trial in Third-Degree Burns Meets Co-Primary Endpoints and...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that its pivotal, controlled clinical trial in the treatment of deep full-thickness (third-degree)...
View ArticleClik here to view.
Clik here to view.
MaxiNovel Disclosed the Study Results of Orally Active PD-1/PD-L1 Inhibitors...
GUANGZHOU, China MaxiNovel Pharmaceuticals, Inc. presented for the first time the preclinical results of its orally active PD-1/PD-L1 inhibitors either as a single agent or in combo studies. The key...
View ArticleClik here to view.
患者安全运动基金会支持《患者安全东京宣言》
加州尔湾 (美国商业资讯) — 患者安全运动基金会(PSMF)宣布支持《患者安全东京宣言》，该宣言由日本、德国和英国在2018年4月13-14日于日本东京召开的第三届全球患者安全部长级峰会上提出。该宣言敦促各国加快迈向增进全球患者安全的进程，方法是通过步调一致的激励机制、增加透明度、落实各项惯例，这些惯例认可医疗保健安全和品质不断改进的重要性。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Kansai Paint Group Announces First Ever Anti-Mosquito Paint Approved By the EPA
TROY, Mich. Kansai Paint Group, a global manufacturer of paints and coatings, (Head office: Osaka Japan, President and CEO: Hiroshi Ishino) has announced approval from the U.S. Environmental...
View ArticleClik here to view.
Vaxart Announces $5 Million Inavir® Revenue Milestone
SOUTH SAN FRANCISCO, Calif. Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today that...
View ArticleClik here to view.
新研究调查Masimo SpHb®在术后红细胞(RBC)输血最佳实践中的功用
葡萄牙里斯本 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布了患者血象管理、止血和栓塞促进网络(NATA) 2018年度年会上呈报的一份摘要中的发现，该研究的研究人员调查了Masimo无创连续血红蛋白(SpHb®)作为术后患者血象管理(PBM)的一部分在支持和提升红细胞(RBC)输血最佳实践中的功用1。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.